ASND
Ascendis Pharma A/S
NASDAQ · DKHealthcareBiotechnology
$251.76-3.54%
Price as of Jul 20, 2026
ASND capital
Ascendis Pharma A/S capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 1.84x
- Net debt / equity
- 0.66x
- Debt / assets
- 0.45x
- Debt / EBITDA
- 72.56x
- Net debt / EBITDA
- 26.21x
Liquidity & coverage
- Current ratio
- 1.00x
- Quick ratio
- 0.72x
- Cash ratio
- 0.51x
- Interest coverage
- -0.04x
- EBITDA / interest
- 0.07x
- Working capital
- -$5.1M
Cash & dividend
- FCF / debt
- 0.05x
- Cash flow / debt
- 0.06x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.